SEC Filing Details
Document Details
Form
Filing Date
Jul 19, 2022
Document Date
Jul 18, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Eiger BioPharmaceuticals
Issuer
EIGER BIOPHARMACEUTICALS, INC.
Filer
KELLY-CROSWELL LISA